TOP STORIES
respiratory
COPD

Triple therapy tops dual therapy in COPD in ETHOS study


There is more evidence for the benefit of triple therapy in patients with moderate to severe COPD. The ETHOS trial, published in the NEJM, comprised 8,509 patients with COPD from 26 countries including Australia. Patients with a diagnosis of active...

There is more evidence for the benefit of triple therapy in patients with moderate to severe COPD. The ETHOS trial, published...

Read more